Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1143

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 1143
---
an average price per share of $1.33, and received net proceeds of approximately $0.003 million, after deducting commissions and
other fees of $0.0003 million.

F-21

SIGNATURES

In
accordance with Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

    MIRA
    PHARMACEUTICALS, INC.

    Date:
    March 28, 2025
    By:
    /S/
    Erez Aminov

    Name:
    Erez
    Aminov

    Title:
    
    Chief
    Executive Officer

    (Principal
    Executive Officer)

    By:
    /S/
    Michelle Yanez

    Name:
    Michelle
    Yanez

    Title:
    Chief
    Financial Officer

    (Principal
    Financial Officer)

In
accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.

    Person
     
    Capacity
     
    Date

    /s/
    Erez Aminov
     
    Chief
    Executive Officer and Chairman
     
    March
    28, 2025
  
    Erez
    Aminov

    /s/
    Michelle Yanez
     
    Chief
    Financial Officer
     
    March
    28, 2025
  
    Michelle
    Yanez

    /s/
    Matthew Whalen
     
    Director

    March
    28, 2025
  
    Matthew
    Whalen

    /s/
    Matthew Del Giudice
     
    Director

    March
    28, 2025
  
    Matthew
    Del Giudice

    /s/
    Denil Shekhat
     
    Director

    March
    28, 2025
  
    Denil
    Shekhat

    /s/
    Edward MacPherson
     
    Director

    March
    28, 2025
  
    Edward
    MacPherson

88